Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Jun;123(6):1162-1168.
doi: 10.1097/AOG.0000000000000290.

Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial

Jan E Dickinson  1 , Belinda G Jennings, Dorota A Doherty
Affiliations
Randomized Controlled Trial

Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial

Jan E Dickinson et al. Obstet Gynecol. 2014 Jun.

Abstract

Objective: To compare the efficacy of the vaginal and sublingual administration of the synthetic prostaglandin misoprostol with the currently used oral administration route in second-trimester medical abortion.

Methods: This was a prospective randomized trial of medical abortion with misoprostol after mifepristone priming at 14-24 weeks of gestation. From 2009 to 2013, recruited women received 200 mg mifepristone orally followed 24-48 hours later by an 800-microgram vaginal loading dose of misoprostol. Women were then randomized to receive additional 400-microgram misoprostol doses orally every 3 hours, vaginally every 4 hours, or sublingually every 3 hours. The main outcome was the duration of abortion with emphasis on the proportion of women undelivered 12 hours after the misoprostol loading dose in the three groups.

Results: A total of 302 women were randomized: 100 to oral, 100 to vaginal, and 102 to sublingual misoprostol. The median gestation at recruitment was oral 19.1 weeks (interquartile range 17.2-20.8), vaginal 19.4 weeks (interquartile range 17.3-20.4), and sublingual 19.7 weeks (interquartile range 17.6-21.0). The overall abortion duration was longer in women receiving oral misoprostol: oral 9.5 hours (95% confidence interval [CI] 8.5-11.4), vaginal 7.4 hours (95% CI 6.5-8.2), and sublingual 7.8 hours (95% CI 7.0-9.2). Overall, 84 of 302 (27.8%) women were undelivered at 12 hours, comprising 37.0% (95% CI 28.7-47.8) oral, 20.5% (95% CI 14.0-30.1) vaginal, and 21.0% (95% CI 14.3-30.7) sublingual groups.

Conclusion: Vaginal or sublingual misoprostol administered after a vaginal loading dose in second-trimester medical abortion with mifepristone priming is associated with a shorter time to pregnancy termination compared with an oral regimen.

Clinical trial registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00864799.

Level of evidence: I.

PubMed Disclaimer

Comment in

References

    1. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51–8.
    1. Kapp N, Borgatta L, Stubblefield PG, Vragovic O, Moreno N. Mifepristone in midtrimester medical abortion: a randomized controlled trial. Obstet Gynecol 2007;110:1304–10.
    1. Danielsson-Gemzell K, Lalitkumar S. Second trimester medical abortion with mifepristone–misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008;16(suppl):162–72.
    1. Dickinson JE, Brownell P, McGinnis K, Nathan E. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort. Aust NZ J Obstet Gynaecol 2010;50:60–4.
    1. Ngoc NT, Shochet T, Raghavan S, Blum J, Nga NT, Minh NT, et al.. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion. Obstet Gynecol 2011;118:601–8.

Publication types

Associated data